Statistics

Total Visits

Views
Low-dose metronomic oral cyclophosphamide plus prednisone for castration resistant prostate cancer (CRPC): A retrospective study75

Select a period of time:

Number of views in the range

Views
Low-dose metronomic oral cyclophosphamide plus prednisone for castration resistant prostate cancer (CRPC): A retrospective study43

Views

Views
February 20251
March 202516
April 20253
May 20255
June 20255
July 202513
August 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore16
United States15
Brazil5
Hong Kong3
Austria1
Germany1
Spain1
Morocco1
 

Top cities views

Views
Hong Kong3
Bauru1
Belo Horizonte1
Campo Novo do Parecis1
Canton1
Casablanca1
Cincinnati1
Council Bluffs1
Fort Wayne1
Hampton1